CollPlant Biotechnologies (CLGN) Non-cash Items (2018 - 2021)
CollPlant Biotechnologies (CLGN) posted Non-cash Items of -$2.5 million for Q3 2021, down 7.78% on a QoQ basis from -$2.3 million in Q2 2021, and down 374.73% year-over-year from $918000.0 in Q3 2020.
CollPlant Biotechnologies (CLGN) Non-cash Items (2018 - 2021) Analysis & Trends
CollPlant Biotechnologies' Non-cash Items history runs 4 years deep, the most recent figure standing at -$2.5 million for Q3 2021.
- Quarterly Non-cash Items fell 374.73% year-over-year to -$2.5 million in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $4.0 million (up 210.63% YoY) and the FY2020 annual result came in at -$3.3 million, up 44.08% from the prior year.
- Non-cash Items was -$2.5 million for Q3 2021 at CollPlant Biotechnologies, down from -$2.3 million in the prior quarter.
- Across five years, Non-cash Items topped out at $10.6 million in Q1 2021 and bottomed at -$2.5 million in Q3 2021.
- A 4-year average of -$396266.7 and a median of -$1.2 million in 2018 frame the typical range for Non-cash Items.
- Peak annual rise in Non-cash Items reached 864.04% in 2021, while the deepest fall reached 374.73% in 2021.
- CollPlant Biotechnologies' Non-cash Items stood at $1.0 million in 2018, then tumbled by 298.8% to -$2.0 million in 2019, then climbed by 13.38% to -$1.7 million in 2020, then slumped by 46.46% to -$2.5 million in 2021.
- Business Quant data shows CLGN's Non-cash Items at -$2.5 million in Q3 2021, -$2.3 million in Q2 2021, and $10.6 million in Q1 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -2.52 Mn |
| Sep 30, 2021 | -2.52 Mn |
| Jun 30, 2021 | -2.34 Mn |
| Jun 30, 2021 | -2.34 Mn |
| Mar 31, 2021 | 10.56 Mn |
| Mar 31, 2021 | 10.56 Mn |
| Dec 31, 2020 | -1.72 Mn |
| Dec 31, 2020 | -1.72 Mn |
| Sep 30, 2020 | 918,000.00 |
| Sep 30, 2020 | 918,000.00 |
| Jun 30, 2020 | -1.14 Mn |
| Jun 30, 2020 | -1.14 Mn |
| Mar 31, 2020 | -1.38 Mn |
| Mar 31, 2020 | -1.38 Mn |
| Dec 31, 2019 | -1.99 Mn |
| Dec 31, 2019 | -1.99 Mn |
| Sep 30, 2019 | -1.63 Mn |
| Sep 30, 2019 | -1.63 Mn |
| Jun 30, 2019 | -1.32 Mn |
| Jun 30, 2019 | -1.32 Mn |